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Abstract  
An antimicrobial agent, chloramphenicol, was isolated from Actinobacteria 10CM9. The strain was isolated from lake sediment 
collected from Erçek Lake, Van (38°29'57.76"N and 43°33'10.98"E) and AIA medium was used as a isolation medium. 16S 
rRNA gene sequence analysis that showed the strain belongs to the genus Streptomycetes. A fermentation study in AIA broth 
medium (3L) followed by extraction with EtOAc afforded 105mg of crude extract. A bioactivity-guided fractionation by Open 
Column chromatography on silica gel led to the isolation of one secondary metabolite (10CM19-01, 31 mg). Structures of the 
metabolites were established as chloramphenicol, by means of NMR (1H, 13C and COSY) data. Antimicrobial activity of 10CM9 
was tested by microdilution method against enteropathogenic Escherichia coli 0157:H7 (RSKK 234), methicillin 
resistant Staphylococcus aureus ATCC 43300, vancomycin resistant Enterococcus faecium DSMZ 13590, Candida
albicansDSMZ 5817 and Pseudomonas aeruginosa ATCC 27853. As a result, 0.5 μg/ml, 0.5 μg/ml and 1 μg/ml MIC values 
were observed against Escherichia coli 0157:H7, Enterococcus faecium and Staphylococcus aureus, respectively. 
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1. Introduction 
Actinobacteria which are gram positive prokaryotic organisms that grow generally in soils have capasity of many 
types secondary metabolites production.(Demain, 1999; Henis, 1986). Approximately 50% of Actinobacteria are 
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belong to genus Streptomyces, and approximately 75% of commercially useful antibiotics are derived from this 
genus (Berdy, 2005). Ercek Lake located on east of Turkey is mostly unexplored. To our knowledge no studies have 
reported the antimicrobial activity of Actinobacteria from Ercek Lake. But lake has different ecosystem for different 
organisms and different secondary metabolites. The aim of this study was to isolate bioactive secondary metabolites 
from Actinobacteria obtained lake sediment. 
1.1. Isolation of 10CM9 
Ercek lake sediment sample was collected.  Actinomycetes isolation agar (AIA) (Difco) used for isolation. 
Sediment sample was brought to the laboratory in cold box. Ten grams of wet sediment sample was added to 90 ml 
sterile water and homogenized for 2 h at 100 rpm at room temperature. After serial dilutions, 200 ȝl aliquots were 
plated onto the isolation media in triplicate. The plates were incubated at 28 °C for up to 4 weeks, and the isolate 
was purified in their original isolation media. 
1.2. Sample fermentation and antimicrobial activity screening 
Fermentations of 10CM9 strain was performed in 250 ml flask containing 50 ml media. Broth version of the AIA 
was used for fermentation experiments. Selective antibiotic supplements were also omitted from media 
formulations. Fermentation media was inoculated with 2.5 % (v/v) activated strain and the flasks were incubated by 
shaking (150 rpm) at 28 °C for a week. The fermentation broth was separated from the cells by centrifugation. The 
broth was extracted by half volume of ethyl acetate twice. The combined extract was evaporated under vacuum 
(Heidolph, Germany) at temperatures of 40 °C. The extract was dissolved in 300 ȝl EtOAc and used to identify 
antimicrobial activity. Disk diffusion assays were used to determine the antimicrobial activities of solvent extract 
(CLSI, 2007). Enteropathogenic Escherichia coli 0157:H7 (RSKK 234), methicillin-resistant Staphylococcus aureus 
ATCC 43300, vancomycin-resistant Enterococcus faecium DSMZ 13590, Candida albicans DSMZ 5817, and
Pseudomonas aeruginosa ATCC 27853 were used as test microorganisms. Test bacteria were activated using to 
Mueller–Hinton agar (MHA) and Sabouraud dextrose agar (SDA)  for C. albicans. Bacteria were incubated at 37°C 
and C. albicans at 25 °C for 24 h. Overnight cultures were diluted with sterile water to obtain optical densities 
corresponding to 0.5 McFarland, and they were spread on MHA and SDA in petri dishes. Sterile paper disks (6 mm 
in diameter) applicated with 30 ȝl of EtOAc extracts then allowed to dry for 30 min. After, they were placed on the 
previously inoculated plates and allowed to diffuse for an additional 2 h at 4 °C. All plates were incubated at 37 °C 
for 24 h. The diameters of the inhibition zones were measured in milimeters. MIC (minimum inhibition 
consantration) microdilution method was tried to determine to microbial activity of pure metabolite (CLSI 2007).  
1.3. DNA extraction and PCR amplification 
Total genomic DNA was extracted from 10CM9 by FastDNA™2-ml SPIN Kit for Soil (MP). Polymerase chain 
reactions (PCR) were performed with the G-Storm® PCR system (Applied Biosystems). The PCR amplification 
was carried out in 50 ȝl reaction volumes containing 0.2 mM primer, 0.4 mM dNTP, 1.25 U of Taq DNA 
polymerase (GoTaq® Hot Start Polymerase, 10 mM PCR buffer, 1.5 mM MgCl2 and 20–50 ng of genomic DNA 
template. The primers used for the amplification of the 16S rDNA were F27 (5-AGAGTTTGATCCTGGCTCAG-3) 
and R1492 (5-TACGGCTACCTTGTTACGACTT-3). The PCR conditions for 16S rDNA reactions were: one cycle 
of denaturation for 5 min at 94 °C; 30 amplification cycles consisting of denaturation (94 °C for 30 s), primer 
annealing (56 °C for 40 s), and primer extension (72 °C for 90 s); and a final extension of 5 min at 72 °C (Gontang 
et al., 2007). The 16S rDNA amplicons were cleaned with a GeneJET™ PCR Purification Kit (Fermentas) 
according to manufacturers’ recommendations.
1.4. Bioactivity guidig purification 
Purification study was based on bioactivity. Firstly isolate 10CM9 was fermented with AIA broth medium (3L). 
Fermentation broth was extracted with EtOAc and obtained 105mg of crude extract. A bioactivity-guided 
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fractionation by Open Column chromatography on silica gel led to the isolation of one secondary metabolite 
(10CM19-01, 31 mg). NMR (1H, 13C, and COSY) data were analyzed for determine of structure.
1.5. Analyses and Results 
Firsty the isolate 10CM9 was sequenced for its 16S rDNA gene region following PCR amplification and 
purification. Gene bank accession numbers JX051283 sequence data was used for BLAST analysis.   Bioactivity 
guided isolation from crude extract concluded to determine one active metabolite (10CM9-01). Consequently, that 
compound had efficient antimicrobial activity and MIC value (Table.1 and 2). Active metabolite NMR data (Fig 1 
and 2) were collected and analyzed. 
As a result, 10CM9 was identified Streptomyces sp. 10CM9. Structure of 10CM9-01 was determined as 
chloramphenicol by using NMR data. 
 
  
Fig. 1. Spectrum of (a)  1H NMR; (b) 13C NMR ; (c) COSY NMR of 10CM9-01 (DMSO-D6, 100 MHz) 
 
Fig. 2. (a) 1H  and (b) 13C NMR data of 10CM9-01 
Table 1. Antimicrobial activity of 10CM9 EtOAc ectract  (30 μl) 
Test organisms Inhibiton zon (mm)  
Escherichia coli 0157:H7  21  








Table 2. MIC value of 10CM9-1 
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Test organisms MIC value  (μg/ml ) 
Escherichia coli 0157:H7  0.5 
Staphylococcus aureus 1 
Enterococcus faecium 0.5 
2. Conclusion 
As a result, chloramphenicol is not a new antibiotic. But different organisms produce chloramphenicol (Larsen et 
al., 2005). In this study, it purificates from different organism Streptomyces sp. 10CM9 obtained from Ercek (Van) 
sediment sample. Also Streptomycetes isolate frequently dominant by traditional agar plate method ((Iwai and 
Takahashi, 1992; Bascom-Slack et al., 2009). Besides different media activates different secondary metabolite gene 
region. For advanced studies, different media prefer to fermentation and obtain different pure metabolites from
Streptomyces sp. 10CM9.  
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